Highlights
• According to the reports, the approval from the DCGI is subject to two conditions
• It is stated that if these clinical trials are successful, the vaccine will be available at a cheaper cost
• Union Minister Dr Harsh Vardhan said if everything goes well, COVAXIN will be available by the year end
According to the reports, Hyderabad-based Bharat Biotech who had developed India&r....
Tags : COVAXIN, Bharat Biotech, DCGI, ICMR, NIV,
comments (0)